共 316 条
[1]
Chan AC(2010)Therapeutic antibodies for autoimmunity and inflammation Nat Rev Immunol 10 301-316
[2]
Carter PJ(2013)Antibody therapeutics in cancer Science 341 1192-1198
[3]
Sliwkowski MX(2008)The clinical pharmacology of therapeutic monoclonal antibodies in the treatment of malignancy; have the magic bullets arrived? Br J Clin Pharmacol 66 6-19
[4]
Mellman I(2009)Production of therapeutic antibodies with controlled fucosylation MAbs 1 230-236
[5]
Newsome BW(2003)The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity J Biol Chem 278 3466-3473
[6]
Ernstoff MS(2012)Quantitative evaluation of fucose reducing effects in a humanized antibody on Fcγ receptor binding and antibody-dependent cell-mediated cytotoxicity activities MAbs 4 326-340
[7]
Yamane-Ohnuki N(2013)Preclinical activity of the type II CD20 antibody GA101 (obinutuzumab) compared with rituximab and ofatumumab in vitro and in xenograft models Mol Cancer Ther 12 2031-2042
[8]
Satoh M(2014)Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions N Engl J Med 370 1101-1110
[9]
Shinkawa T(2005)Control of recombinant monoclonal antibody effector functions by fc N-glycan remodeling in vitro Biotechnol Prog 21 1644-1652
[10]
Nakamura K(2016)Effect of high mannose glycan pairing on IgG antibody clearance Biologicals 44 163-169